Innovation Articles. App Notes, Case Studies. & White Papers

1. Building A Resilient Supply Chain For Complex IVD Reagents (Or Proteins) 11/3/2026

   Explore how matching expression systems to diagnostic protein needs can improve yield, consistency, and scalability while reducing supply risks for IVD assays.

2. From LNP Delivery To Functional CAR-T: Rethinking Targeting 10/16/2026

   Optimizing LNPs for in vivo CAR-T requires aligning target selection, formulation design, and delivery performance to achieve functional CAR expression in desired T-cell populations while balancing specificity, safety, dosing flexibility, and manufacturability.

3. Top 5 Things To Know About The Lipid Nanoparticle Portfolio 10/13/2026

   Lipids that shift charge with pH can be chosen to fit the application and delivery route. Varied pKa and biodegradability give developers room to match each therapeutic target.

4. Expand mRNA-LNP Nanomedicine Potential By Optimizing Lipids 10/13/2026

   Ionizable lipid selection ratios shape how well lipid nanoparticles deliver nucleic acids, and empirical testing shows that similar physical properties can still produce very different performance.

5. Why Protein Motion Matters As Much As Protein Structure 9/30/2026

   Protein structures are not static. See how conformational changes influence physiological function and how electron paramagnetic resonance spectroscopy provides insights into effective design.

6. How Does EPR Spectroscopy Complement Cryo-EM? 9/30/2026

   Discover how EPR complements structural maps by resolving flexible regions, detecting hidden conformational states, identifying differences between grid-based and solution conditions, and revealing the dynamic changes that connect molecular structure with biological function.

7. 7 Causes Of Unresolved Density And How To Investigate Them 9/27/2026

   Missing cryo-EM density does not always indicate disorder. Learn how flexibility, conformational variation, incomplete occupancy, and sample heterogeneity can shape what is visible in a protein structure.

8. Resolving In-Vitro Diagnostic Supply Chain Constraints 9/27/2026

   Explore strategies for securing recombinant proteins while addressing supply continuity, batch consistency, scale-up challenges, and quality requirements for clinical validation and commercialization.

9. Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks 9/26/2026

   Overcome biomanufacturing tradeoffs with expression strategies that enhance stability, scalability, and production consistency.

10. Beyond The Bioreactor Scaling CGT Ancillary Materials With The EntoEngine™ 9/26/2026

    Growing demand for cell and gene therapies is increasing pressure on cytokine production. Explore interleukin manufacturing, quality, consistency, safety, scalability, and supply reliability.